1. Home
  2. CION vs FLGT Comparison

CION vs FLGT Comparison

Compare CION & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CION
  • FLGT
  • Stock Information
  • Founded
  • CION 2011
  • FLGT 2011
  • Country
  • CION United States
  • FLGT United States
  • Employees
  • CION N/A
  • FLGT N/A
  • Industry
  • CION Finance/Investors Services
  • FLGT Medical Specialities
  • Sector
  • CION Finance
  • FLGT Health Care
  • Exchange
  • CION Nasdaq
  • FLGT Nasdaq
  • Market Cap
  • CION 548.0M
  • FLGT 587.3M
  • IPO Year
  • CION N/A
  • FLGT 2016
  • Fundamental
  • Price
  • CION $10.26
  • FLGT $21.95
  • Analyst Decision
  • CION Sell
  • FLGT Buy
  • Analyst Count
  • CION 2
  • FLGT 3
  • Target Price
  • CION $10.75
  • FLGT $25.33
  • AVG Volume (30 Days)
  • CION 286.9K
  • FLGT 209.4K
  • Earning Date
  • CION 11-06-2025
  • FLGT 08-01-2025
  • Dividend Yield
  • CION 14.54%
  • FLGT N/A
  • EPS Growth
  • CION N/A
  • FLGT N/A
  • EPS
  • CION N/A
  • FLGT N/A
  • Revenue
  • CION $225,839,000.00
  • FLGT $303,223,000.00
  • Revenue This Year
  • CION N/A
  • FLGT $15.19
  • Revenue Next Year
  • CION N/A
  • FLGT $10.58
  • P/E Ratio
  • CION N/A
  • FLGT N/A
  • Revenue Growth
  • CION N/A
  • FLGT 4.31
  • 52 Week Low
  • CION $8.51
  • FLGT $14.57
  • 52 Week High
  • CION $12.71
  • FLGT $23.56
  • Technical
  • Relative Strength Index (RSI)
  • CION 45.61
  • FLGT 62.67
  • Support Level
  • CION $10.17
  • FLGT $21.47
  • Resistance Level
  • CION $10.86
  • FLGT $22.61
  • Average True Range (ATR)
  • CION 0.16
  • FLGT 0.55
  • MACD
  • CION -0.08
  • FLGT -0.03
  • Stochastic Oscillator
  • CION 12.99
  • FLGT 65.26

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: